U.S. federal trademark · Serial No. 97601016 · Reg. No. 7256367
Pharmaceutical and biologic preparations for use in oncology and immuno-oncology; biological components being a component in therapeutic preparations, namely, engineered exosomes delivering antisense oligonucleotides to inhibit tumor growth and induce anti-tumor immune response; therapeutic agents for the treatment of cancer and immuno-oncological diseases; therapeutic agents for inducing anti-tumor immune response
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.